Cargando…
30 days mortality prediction and risk factor analysis of Asian patients with ACS using interpretable machine learning algorithm
BACKGROUND: Thrombolysis in Myocardial Infarction (TIMI) is used to predict the mortality rate in patients with acute coronary syndrome (ACS). TIMI was developed with limited data on the Asian cohort and was based on the Western cohort. STEMI and NSTEMI have separate TIMI scores. There has been limi...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9779796/ http://dx.doi.org/10.1093/ehjdh/ztac076.2783 |
_version_ | 1784856697479626752 |
---|---|
author | Kasim, S Malek, S Ibrahim, K S Lim, B F Aziz, M F |
author_facet | Kasim, S Malek, S Ibrahim, K S Lim, B F Aziz, M F |
author_sort | Kasim, S |
collection | PubMed |
description | BACKGROUND: Thrombolysis in Myocardial Infarction (TIMI) is used to predict the mortality rate in patients with acute coronary syndrome (ACS). TIMI was developed with limited data on the Asian cohort and was based on the Western cohort. STEMI and NSTEMI have separate TIMI scores. There has been limited research on Asian ACS patients using interpretable machine learning (ML) algorithms. PURPOSE: To construct a single 30-day mortality risk scoring system, as well as identify and analyse risk factors in ASIAN patients with ACS, that is applicable to both STEMI and NSTEMI patients, using an interpretable ML algorithm. METHODS: The National Cardiovascular Disease Database registry data of 9054 patients was used. 70% of the data was used for algorithm development, with the remaining 30% used for validation Fifty-four parameters were considered, demographics, cardiovascular risk, medications, and clinical variables. To provide better guidance and advice for clinical judgement, the gradient boosting algorithm (XGBoost) for classification analysis and SHapley Additive exPlanation (SHAP) value analysis graphs were used. Each indicator's SHAP value indicates the impact on model output (mortality) and was calculated using the XGBoost model. The performance evaluation metric was the area under the curve (AUC). The model was validated with a validation dataset and compared to the conventional score TIMI for STEMI and NSTEMI. RESULTS: The performance on validation dataset of the XGBoost algorithm using the top ten predictors from SHAP for; STEMI (AUC = 0.8534, 95% CI: 0.8226–0.8842, Accuracy: 0.8053, Sensitivity: 0.73125, Specificity: 0.81355) and NSTEMI (AUC = 0.8145, 95% CI: 0.77–0.8589, Accuracy: 0.7972, Sensitivity: 0.64356, Specificity: 0.81232) outperformed TIMI score (STEMI AUC = 0.785, NSTEMI AUC = 0.543). Killip class, age, heart rate, fasting blood glucose, ACEI, creatine kinase, systolic blood pressure, HDLC, cardiac catheterization, and oralhypogly are the top ten predictors chosen by the SHAP feature selection in ascending order. Cardiac catheterization and pharmacotherapy drugs as selected predictors improve mortality prediction in STEMI and NSTEMI patients compared to TIMI. The variable names are displayed on the y-axis in ascending order of importance. The average SHAP value is shown next to them. The SHAP value is shown on the x-axis. The colour represents the value of the feature, ranging from small to large, allowing comprehension of the distribution of the SHAP values for each feature (Figure 1). We can see that having a high killip class and being older are linked to a lower survival rate in ACS patients. Cardiac catheterization procedures, as well as the use of ACEI and OHA, both improve patient mortality (Figure 2). CONCLUSIONS: A single algorithm would classify ACS patients better than TIMI, which requires two distinct scores. In order to better predict 30-day mortality in an ASIAN population, interpretable ML can be used. FUNDING ACKNOWLEDGEMENT: Type of funding sources: Public grant(s) – National budget only. Main funding source(s): Technology Development Fund 1 |
format | Online Article Text |
id | pubmed-9779796 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-97797962023-01-27 30 days mortality prediction and risk factor analysis of Asian patients with ACS using interpretable machine learning algorithm Kasim, S Malek, S Ibrahim, K S Lim, B F Aziz, M F Eur Heart J Digit Health Abstracts BACKGROUND: Thrombolysis in Myocardial Infarction (TIMI) is used to predict the mortality rate in patients with acute coronary syndrome (ACS). TIMI was developed with limited data on the Asian cohort and was based on the Western cohort. STEMI and NSTEMI have separate TIMI scores. There has been limited research on Asian ACS patients using interpretable machine learning (ML) algorithms. PURPOSE: To construct a single 30-day mortality risk scoring system, as well as identify and analyse risk factors in ASIAN patients with ACS, that is applicable to both STEMI and NSTEMI patients, using an interpretable ML algorithm. METHODS: The National Cardiovascular Disease Database registry data of 9054 patients was used. 70% of the data was used for algorithm development, with the remaining 30% used for validation Fifty-four parameters were considered, demographics, cardiovascular risk, medications, and clinical variables. To provide better guidance and advice for clinical judgement, the gradient boosting algorithm (XGBoost) for classification analysis and SHapley Additive exPlanation (SHAP) value analysis graphs were used. Each indicator's SHAP value indicates the impact on model output (mortality) and was calculated using the XGBoost model. The performance evaluation metric was the area under the curve (AUC). The model was validated with a validation dataset and compared to the conventional score TIMI for STEMI and NSTEMI. RESULTS: The performance on validation dataset of the XGBoost algorithm using the top ten predictors from SHAP for; STEMI (AUC = 0.8534, 95% CI: 0.8226–0.8842, Accuracy: 0.8053, Sensitivity: 0.73125, Specificity: 0.81355) and NSTEMI (AUC = 0.8145, 95% CI: 0.77–0.8589, Accuracy: 0.7972, Sensitivity: 0.64356, Specificity: 0.81232) outperformed TIMI score (STEMI AUC = 0.785, NSTEMI AUC = 0.543). Killip class, age, heart rate, fasting blood glucose, ACEI, creatine kinase, systolic blood pressure, HDLC, cardiac catheterization, and oralhypogly are the top ten predictors chosen by the SHAP feature selection in ascending order. Cardiac catheterization and pharmacotherapy drugs as selected predictors improve mortality prediction in STEMI and NSTEMI patients compared to TIMI. The variable names are displayed on the y-axis in ascending order of importance. The average SHAP value is shown next to them. The SHAP value is shown on the x-axis. The colour represents the value of the feature, ranging from small to large, allowing comprehension of the distribution of the SHAP values for each feature (Figure 1). We can see that having a high killip class and being older are linked to a lower survival rate in ACS patients. Cardiac catheterization procedures, as well as the use of ACEI and OHA, both improve patient mortality (Figure 2). CONCLUSIONS: A single algorithm would classify ACS patients better than TIMI, which requires two distinct scores. In order to better predict 30-day mortality in an ASIAN population, interpretable ML can be used. FUNDING ACKNOWLEDGEMENT: Type of funding sources: Public grant(s) – National budget only. Main funding source(s): Technology Development Fund 1 Oxford University Press 2022-12-22 /pmc/articles/PMC9779796/ http://dx.doi.org/10.1093/ehjdh/ztac076.2783 Text en Reproduced from: European Heart Journal, Volume 43, Issue Supplement_2, October 2022, ehac544.2783, https://doi.org/10.1093/eurheartj/ehac544.2783 by permission of Oxford University Press on behalf of the European Society of Cardiology. The opinions expressed in the Journal item reproduced as this reprint are those of the authors and contributors, and do not necessarily reflect those of the European Society of Cardiology, the editors, the editorial board, Oxford University Press or the organization to which the authors are affiliated. The mention of trade names, commercial products or organizations, and the inclusion of advertisements in this reprint do not imply endorsement by the Journal, the editors, the editorial board, Oxford University Press or the organization to which the authors are affiliated. The editors and publishers have taken all reasonable precautions to verify drug names and doses, the results of experimental work and clinical findings published in the Journal. The ultimate responsibility for the use and dosage of drugs mentioned in this reprint and in interpretation of published material lies with the medical practitioner, and the editors and publisher cannot accept liability for damages arising from any error or omissions in the Journal or in this reprint. Please inform the editors of any errors. © The Author(s) 2022. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Abstracts Kasim, S Malek, S Ibrahim, K S Lim, B F Aziz, M F 30 days mortality prediction and risk factor analysis of Asian patients with ACS using interpretable machine learning algorithm |
title | 30 days mortality prediction and risk factor analysis of Asian patients with ACS using interpretable machine learning algorithm |
title_full | 30 days mortality prediction and risk factor analysis of Asian patients with ACS using interpretable machine learning algorithm |
title_fullStr | 30 days mortality prediction and risk factor analysis of Asian patients with ACS using interpretable machine learning algorithm |
title_full_unstemmed | 30 days mortality prediction and risk factor analysis of Asian patients with ACS using interpretable machine learning algorithm |
title_short | 30 days mortality prediction and risk factor analysis of Asian patients with ACS using interpretable machine learning algorithm |
title_sort | 30 days mortality prediction and risk factor analysis of asian patients with acs using interpretable machine learning algorithm |
topic | Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9779796/ http://dx.doi.org/10.1093/ehjdh/ztac076.2783 |
work_keys_str_mv | AT kasims 30daysmortalitypredictionandriskfactoranalysisofasianpatientswithacsusinginterpretablemachinelearningalgorithm AT maleks 30daysmortalitypredictionandriskfactoranalysisofasianpatientswithacsusinginterpretablemachinelearningalgorithm AT ibrahimks 30daysmortalitypredictionandriskfactoranalysisofasianpatientswithacsusinginterpretablemachinelearningalgorithm AT limbf 30daysmortalitypredictionandriskfactoranalysisofasianpatientswithacsusinginterpretablemachinelearningalgorithm AT azizmf 30daysmortalitypredictionandriskfactoranalysisofasianpatientswithacsusinginterpretablemachinelearningalgorithm |